Chemoinformaics analysis of CHOLEST-7-EN-3-BETA-OL
| Molecular Weight | 386.664 | nRot | 5 |
| Heavy Atom Molecular Weight | 340.296 | nRig | 20 |
| Exact Molecular Weight | 386.355 | nRing | 4 |
| Solubility: LogS | -7.108 | nHRing | 0 |
| Solubility: LogP | 7.187 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 74 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 28 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 46 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 27 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 76.5645 |
| nHD | 1 | BPOL | 46.1475 |
| QED | 0.488 |
| Synth | 4.337 |
| Natural Product Likeliness | 2.577 |
| NR-PPAR-gamma | 0.024 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.021 |
| Pgp-sub | 0 |
| HIA | 0.005 |
| CACO-2 | -4.681 |
| MDCK | 0.0000129 |
| BBB | 0.934 |
| PPB | 0.985544 |
| VDSS | 1.412 |
| FU | 0.0129441 |
| CYP1A2-inh | 0.081 |
| CYP1A2-sub | 0.341 |
| CYP2c19-inh | 0.101 |
| CYP2c19-sub | 0.878 |
| CYP2c9-inh | 0.149 |
| CYP2c9-sub | 0.522 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.321 |
| CYP3a4-inh | 0.296 |
| CYP3a4-sub | 0.307 |
| CL | 16.412 |
| T12 | 0.014 |
| hERG | 0.009 |
| Ames | 0.018 |
| ROA | 0.041 |
| SkinSen | 0.108 |
| Carcinogencity | 0.034 |
| EI | 0.017 |
| Respiratory | 0.881 |
| NR-Aromatase | 0.014 |
| Antiviral | No |
| Prediction | 0.714122 |